Literature DB >> 11442200

Chemotherapy for patients with multiple parasitic infections.

P L Chiodini1.   

Abstract

Multiple parasitic infections have become increasingly recognized as a result of improvements in laboratory diagnosis and a growing population of immunocompromised individuals. This review examines the principles of chemotherapy in groupings of multiple infections which are of particular clinical significance.

Entities:  

Mesh：

Year:  2001        PMID： 11442200     DOI： 10.1017/s0031182000017674

Source DB:  PubMed          Journal:  Parasitology        ISSN： 0031-1820            Impact factor:   3.234


  6 in total

Review 1.  The nature and consequences of coinfection in humans.

Authors:  Emily C Griffiths; Amy B Pedersen; Andy Fenton; Owen L Petchey
Journal:  J Infect       Date:  2011-06-16       Impact factor: 6.072

2.  Analysis of a summary network of co-infection in humans reveals that parasites interact most via shared resources.

Authors:  Emily C Griffiths; Amy B Pedersen; Andy Fenton; Owen L Petchey
Journal:  Proc Biol Sci       Date:  2014-03-11       Impact factor: 5.349

3.  Salmonella typhimurium Infection Reduces Schistosoma japonicum Worm Burden in Mice.

Authors:  Xiaoyang Zhu; Lu Chen; Junfang Wu; Huiru Tang; Yulan Wang
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

4.  Associations between soil-transmitted helminthiasis and viral, bacterial, and protozoal enteroinfections: a cross-sectional study in rural Laos.

Authors:  Anna N Chard; Kelly K Baker; Kevin Tsai; Karen Levy; Jeticia R Sistrunk; Howard H Chang; Matthew C Freeman
Journal:  Parasit Vectors       Date:  2019-05-07       Impact factor: 3.876

Review 5.  Viral coinfections in COVID-19.

Authors:  Parisa S Aghbash; Narges Eslami; Milad Shirvaliloo; Hossein B Baghi
Journal:  J Med Virol       Date:  2021-06-12       Impact factor: 20.693

6.  Non-SARS-CoV-2 genome sequences identified in clinical samples from COVID-19 infected patients: Evidence for co-infections.

Authors:  Mohamed A Abouelkhair
Journal:  PeerJ       Date:  2020-11-02       Impact factor: 2.984
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.